Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00625326
Recruitment Status : Completed
First Posted : February 28, 2008
Last Update Posted : April 27, 2011
Information provided by:
Deltanoid Pharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2008
  Actual Study Completion Date : June 2009
  Certification/Extension First Submitted : December 1, 2010